Skip to main content

Table 2 Prevalence of daytime, night-time and early-morning symptoms at baseline

From: Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)

 

Patients with symptoms (%)

Night-time symptoms

 

 Any

88.3

 Cough

72.7

 Wheezing

59.3

 Shortness of breath

67.2

 Difficulty bringing up phlegm

44.0

 Nocturnal awakenings

57.4

Early-morning symptoms

 

 Any

94.4

 Cough

81.5

 Wheezing

57.4

 Shortness of breath

77.6

 Difficulty bringing up phlegm

48.6

 Limitation of early-morning activities

90.6

  1. Data are for the pooled ITT population
  2. ITT intent-to-treat
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us